KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Dec 2024 value amounting to $36,000.

  • Rigel Pharmaceuticals' Capital Expenditures was N/A to $26,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $252,000, marking a year-over-year change of. This contributed to the annual value of $36,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Rigel Pharmaceuticals' Capital Expenditures is $36,000, which was down 92.00% from $450,000 recorded in FY2022.
  • In the past 5 years, Rigel Pharmaceuticals' Capital Expenditures registered a high of $1.3 million during FY2020, and its lowest value of $36,000 during FY2024.
  • Moreover, its 2-year median value for Capital Expenditures was $243,000 (2022), whereas its average is $243,000.
  • Data for Rigel Pharmaceuticals' Capital Expenditures shows a maximum YoY plummeted of 50.32% (in 2021) over the last 5 years.
  • Yearly analysis of 4 years shows Rigel Pharmaceuticals' Capital Expenditures stood at $1.3 million in 2020, then slumped by 50.32% to $627,000 in 2021, then declined by 28.23% to $450,000 in 2022, then reached $36,000 in 2024.